fasciotomy: if it was suspected with ACS, the fasciotomy was conducted. but if the blister observed, it means decreased conmpartment sydrome. therefore, the blister observed can avoid unnecessary fasciotomy to patients suspected with ACS
Study summary
Acute compartment syndrome (ACS) is defined as a clinical entity originated from trauma or other conditions, and remains challenging to diagnose and treat effectively. Threre is the controversy in diagnosing, treating ACS. It was found that there was no criterion about the ACS, and result unnecessary osteotomy. The presence of clinical assessment (5P) always means the necrosis of muscles and was the most serious or irreversible stage of ACS. Besides pressure methods, the threshold of pressure identifying ACS was also controversial.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Fracture patients with Schatzker V and VI,
* Who were older than eighteen years.
Exclusion Criteria:
* The exclusion criteria were pathologic, extra-articular proximal tibial fracture,
* Patients who was eighteen years or younger.
* Patients treated with other implant,
* underwent conservative management were also excluded.
Primary outcome measure(s)
injury mechanism — up to 1 weeks The relative data was collected about injury mechanism such as high falling accident, traffic accident, fall from standing height,Crushing
the time when the blister appeared — up to 4 weeks The relative data was collected about the time when the blister appeared after injury
time to reconstructive surgery — time to when the surgery was conducted after 2 weeks The relative data was collected about time to reconstructive surgery
union time — through study completion, an average of 1 year The relative data was collected about union time
No non-anatomic gap or step (larger than 5 mm) — through study completion, an average of 1 year The relative data was collected about complications
secondary loss of reduction — through study completion, an average of 1 year The relative data was collected about complications
Deep venous thrombosis — through study completion, an average of 1 year The relative data was collected about complications
superficial wound problems — through study completion, an average of 1 year The relative data was collected about complications
blister skin immunochemistry and immunofluorescence analysis — through study completion, an average of 1 year CK1, 5, 10, claudin 1, 2 and occludin as determined by immunochemistry analysis, and skin barrier proteins; claudin 1, 2 and occludin was determined by immunofluorescence analysis and qPCR.
Trial sites (1)
Facility
City
Region
Status
the Third Hospital of Hebei Medical University
Shijiazhuang
Hebei
Recruiting
More Hebei Medical University Third Hospital trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.